PT1668002E - 2,4-dioxo-3-quinazolinilarilsulfonilureias - Google Patents
2,4-dioxo-3-quinazolinilarilsulfonilureias Download PDFInfo
- Publication number
- PT1668002E PT1668002E PT04789522T PT04789522T PT1668002E PT 1668002 E PT1668002 E PT 1668002E PT 04789522 T PT04789522 T PT 04789522T PT 04789522 T PT04789522 T PT 04789522T PT 1668002 E PT1668002 E PT 1668002E
- Authority
- PT
- Portugal
- Prior art keywords
- sub
- sup
- group
- alkyl
- member selected
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Non-Alcoholic Beverages (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US50856403P | 2003-10-03 | 2003-10-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1668002E true PT1668002E (pt) | 2009-11-25 |
Family
ID=34421757
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT04789522T PT1668002E (pt) | 2003-10-03 | 2004-09-29 | 2,4-dioxo-3-quinazolinilarilsulfonilureias |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7109332B2 (pt) |
| EP (1) | EP1668002B1 (pt) |
| JP (1) | JP2007507551A (pt) |
| KR (1) | KR20060113700A (pt) |
| CN (1) | CN1863798B (pt) |
| AT (1) | ATE448222T1 (pt) |
| AU (1) | AU2004278030C1 (pt) |
| CA (1) | CA2540214A1 (pt) |
| DE (1) | DE602004024093D1 (pt) |
| ES (1) | ES2334795T3 (pt) |
| HK (1) | HK1093973A1 (pt) |
| IL (1) | IL174446A (pt) |
| MX (1) | MXPA06003618A (pt) |
| PL (1) | PL1668002T3 (pt) |
| PT (1) | PT1668002E (pt) |
| WO (1) | WO2005032488A2 (pt) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2803667A1 (en) * | 2003-12-22 | 2014-11-19 | Ajinomoto Co., Inc. | Phenylalanine derivatives |
| AU2005292314B2 (en) * | 2004-09-29 | 2011-11-03 | Portola Pharmaceuticals, Inc. | Substituted 2H-1,3-benzoxazin-4(3H)-ones |
| CA2627719C (en) * | 2005-11-03 | 2016-07-12 | Portola Pharmaceuticals, Inc. | [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto |
| US7834023B2 (en) | 2006-09-20 | 2010-11-16 | Portola Pharmaceuticals, Inc. | Substituted dihydroquinazolines as platelet ADP receptor inhibitors |
| JP2010523590A (ja) | 2007-04-05 | 2010-07-15 | ギリアード・パロ・アルト・インコーポレイテッド | Ａｌｄｈ−２阻害剤としてのキナゾリノン誘導体 |
| JPWO2008133155A1 (ja) | 2007-04-19 | 2010-07-22 | アステラス製薬株式会社 | 二環式ヘテロ環化合物 |
| AU2008247457A1 (en) * | 2007-05-02 | 2008-11-13 | Portola Pharmaceuticals, Inc. | [4-(6-fluoro-7-methylamino-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl)-phenyl] -5-chloro-thiophen-2-yl-sulfonylurea salts, in different crystalline forms, pharmaceutical compositions thereof |
| CN101654441B (zh) * | 2008-08-19 | 2012-10-03 | 信谊药厂 | 抗凝化合物、组合物及其用途 |
| PL2511264T3 (pl) | 2009-01-19 | 2015-08-31 | Abbvie Inc | Środki indukujące apoptozę do leczenia raka oraz chorób immunologicznych i autoimmunologicznych |
| RU2538965C2 (ru) * | 2009-01-19 | 2015-01-10 | Эббви Инк. | Вызывающие апоптоз средства для лечения рака и иммунных и аутоиммунных заболеваний |
| US9481677B2 (en) | 2011-10-31 | 2016-11-01 | Xenon Pharmaceuticals Inc. | Biaryl ether sulfonamides and their use as therapeutic agents |
| WO2013064983A1 (en) | 2011-10-31 | 2013-05-10 | Xenon Pharmaceuticals Inc. | Benzenesulfonamide compounds and their use as therapeutic agents |
| AR091112A1 (es) * | 2012-05-22 | 2015-01-14 | Genentech Inc | Benzamidas n-sustituidas como inhibidores de los canales de sodio nav1.7 |
| EP2870138B1 (en) | 2012-07-06 | 2018-08-22 | Genentech, Inc. | N-substituted benzamides and methods of use thereof |
| KR20150131233A (ko) | 2013-03-14 | 2015-11-24 | 제넨테크, 인크. | 치환된 트리아졸로피리딘 및 이의 사용 방법 |
| JP6227112B2 (ja) | 2013-03-15 | 2017-11-08 | ジェネンテック， インコーポレイテッド | 置換ベンゾオキサゾールとその使用方法 |
| EP3074377B1 (en) | 2013-11-27 | 2018-10-17 | Genentech, Inc. | Substituted benzamides and methods of use thereof |
| US10005724B2 (en) | 2014-07-07 | 2018-06-26 | Genentech, Inc. | Therapeutic compounds and methods of use thereof |
| ES2881228T3 (es) | 2015-02-16 | 2021-11-29 | Univ Queensland | Sulfonilureas y compuestos relacionados y uso de los mismos |
| AU2016268120A1 (en) | 2015-05-22 | 2017-11-30 | Genentech, Inc. | Substituted benzamides and methods of use thereof |
| WO2017035271A1 (en) | 2015-08-27 | 2017-03-02 | Genentech, Inc. | Therapeutic compounds and methods of use thereof |
| JP6987746B2 (ja) | 2015-09-28 | 2022-01-05 | ジェネンテック， インコーポレイテッド | 治療用化合物及びその使用方法 |
| CN108495851A (zh) | 2015-11-25 | 2018-09-04 | 基因泰克公司 | 取代的苯甲酰胺及其使用方法 |
| CN109071426A (zh) | 2016-03-30 | 2018-12-21 | 基因泰克公司 | 取代的苯甲酰胺及其使用方法 |
| JP2019532077A (ja) | 2016-10-17 | 2019-11-07 | ジェネンテック， インコーポレイテッド | 治療用化合物及びその使用方法 |
| CN110546148A (zh) | 2017-03-24 | 2019-12-06 | 基因泰克公司 | 作为钠通道抑制剂的4-哌啶-n-(嘧啶-4-基)色满-7-磺酰胺衍生物 |
| US11465992B2 (en) | 2017-07-07 | 2022-10-11 | Inflazome Limited | Sulfonamide carboxamide compounds |
| WO2019034692A1 (en) | 2017-08-15 | 2019-02-21 | Inflazome Limited | SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3 |
| BR112020003014A2 (pt) | 2017-08-15 | 2020-07-28 | Inflazome Limited | sulfonilureias e sulfoniltioureias como inibidores de vnlrp3 |
| EP3668843A1 (en) | 2017-08-15 | 2020-06-24 | Inflazome Limited | Sulfonylureas and sulfonylthioureas as nlrp3 inhibitors |
| TW202000651A (zh) | 2018-02-26 | 2020-01-01 | 美商建南德克公司 | 治療性組成物及其使用方法 |
| EP3759077A1 (en) | 2018-03-02 | 2021-01-06 | Inflazome Limited | Novel compounds |
| US10947251B2 (en) | 2018-03-30 | 2021-03-16 | Genentech, Inc. | Therapeutic compounds and methods of use thereof |
| WO2020116662A1 (ja) | 2018-12-06 | 2020-06-11 | 第一三共株式会社 | シクロアルカン−１，３−ジアミン誘導体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9702774D0 (sv) | 1997-07-22 | 1997-07-22 | Astra Pharma Prod | Novel compounds |
| WO1999036425A1 (en) | 1998-01-15 | 1999-07-22 | Cor Therapeutics, Inc. | Platelet adp receptor inhibitors |
| JP4574100B2 (ja) * | 2000-02-04 | 2010-11-04 | ポートラ ファーマシューティカルズ， インコーポレイテッド | 血小板ａｄｐレセプターインヒビター |
| US6906063B2 (en) | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
-
2004
- 2004-09-29 AU AU2004278030A patent/AU2004278030C1/en not_active Ceased
- 2004-09-29 US US10/956,004 patent/US7109332B2/en not_active Expired - Fee Related
- 2004-09-29 CA CA002540214A patent/CA2540214A1/en not_active Abandoned
- 2004-09-29 EP EP04789522A patent/EP1668002B1/en active Active
- 2004-09-29 MX MXPA06003618A patent/MXPA06003618A/es active IP Right Grant
- 2004-09-29 WO PCT/US2004/032921 patent/WO2005032488A2/en active Application Filing
- 2004-09-29 PL PL04789522T patent/PL1668002T3/pl unknown
- 2004-09-29 KR KR1020067008644A patent/KR20060113700A/ko not_active Application Discontinuation
- 2004-09-29 PT PT04789522T patent/PT1668002E/pt unknown
- 2004-09-29 ES ES04789522T patent/ES2334795T3/es active Active
- 2004-09-29 CN CN2004800287913A patent/CN1863798B/zh not_active Expired - Fee Related
- 2004-09-29 AT AT04789522T patent/ATE448222T1/de active
- 2004-09-29 DE DE602004024093T patent/DE602004024093D1/de active Active
- 2004-09-29 JP JP2006534290A patent/JP2007507551A/ja active Pending
-
2006
- 2006-03-21 IL IL174446A patent/IL174446A/en not_active IP Right Cessation
- 2006-12-13 HK HK06113688.4A patent/HK1093973A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005032488A3 (en) | 2005-05-12 |
| MXPA06003618A (es) | 2006-08-11 |
| HK1093973A1 (en) | 2007-03-16 |
| AU2004278030B2 (en) | 2010-07-01 |
| KR20060113700A (ko) | 2006-11-02 |
| PL1668002T3 (pl) | 2010-02-26 |
| EP1668002B1 (en) | 2009-11-11 |
| ATE448222T1 (de) | 2009-11-15 |
| CA2540214A1 (en) | 2005-04-14 |
| EP1668002A2 (en) | 2006-06-14 |
| AU2004278030A1 (en) | 2005-04-14 |
| AU2004278030C1 (en) | 2010-12-02 |
| US20050107357A1 (en) | 2005-05-19 |
| WO2005032488A2 (en) | 2005-04-14 |
| JP2007507551A (ja) | 2007-03-29 |
| EP1668002A4 (en) | 2006-12-20 |
| DE602004024093D1 (de) | 2009-12-24 |
| IL174446A (en) | 2012-02-29 |
| IL174446A0 (en) | 2006-08-01 |
| ES2334795T3 (es) | 2010-03-16 |
| US7109332B2 (en) | 2006-09-19 |
| CN1863798B (zh) | 2011-08-31 |
| CN1863798A (zh) | 2006-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1093973A1 (en) | 2,4-dioxo-3-quinazolinylaryl sulfonylureas | |
| BG104248A (en) | Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides | |
| MXPA04004457A (es) | Novedosos derivados de 1,2,4-tiadiazolio como moduladores del receptor de melanocortina. | |
| DE60330150D1 (en) | Derivate des 2-trifluormethyl-6-aminopurins als phosphodiesterase 4 inhibitoren | |
| GR3034398T3 (en) | 2-[1',2',4'-triazol-3'-yloxymethylene]-anilides and their use as pest-control agents | |
| DE50204803D1 (en) | 4-alkylsubstituierte thienyloxy-pyrididne als herbizide | |
| IL157179A0 (en) | Fused heterocyclic compounds | |
| HUP0402150A2 (hu) | A CB1 jelzésű kannabinoid receptorra nézve agonista, parciális agonista vagy antagonista hatású 1H-imidazol-származékok, eljárás az előállításukra, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk gyógyszerkészítmények előállítására | |
| NZ511311A (en) | Pyrimidinylbenzimidazole and triazinylbenzimidazole derivatives useful as agricultural, horticultural bactericides | |
| WO2003084937A3 (en) | Pyrimidinedione derivatives useful for the treatment of inflammation and immunological diseases | |
| TW200609218A (en) | Bicyclic compounds | |
| WO2004004730A3 (en) | 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders | |
| HRP20050082A2 (en) | 6-amino-1h-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors | |
| MY146599A (en) | New azetidine compounds | |
| DE60336735D1 (de) | Neue biologischaktive molekü le | |
| IL160874A0 (en) | 4-imidazolin-2-one derivatives | |
| MXPA04003278A (es) | Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina. | |
| PT1628968E (pt) | Compostos de 4-imidazolin-2-ona | |
| MXPA02003952A (es) | Derivados de imidazol como inhibidores de la fosfodieterasa vii. | |
| ATE238300T1 (de) | (3,4-dihydro-2h-benzo(1,4)oxazinyl-methyl)-3-(1 - indol-3-yl)-alkylamine | |
| MY139258A (en) | Carbamoyl-type benzofuran derivatives | |
| GB0106419D0 (en) | Novel compounds | |
| CA2009542A1 (en) | Cyclic guanidines as calcium antagonists | |
| TW326385B (en) | Iminooxybenzyl compounds, their preparation and their use |